Yabao Pharmaceutical Group Co Ltd (600351) — Capital Reinvestment Ratio
Yabao Pharmaceutical Group Co Ltd (600351) has a Capital Reinvestment Ratio of 0.06x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥129.49 Million) in capital expenditures (CN¥7.58 Million). Check Yabao Pharmaceutical Group Co Ltd (600351) tangible net worth to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Yabao Pharmaceutical Group Co Ltd Capital Reinvestment Ratio (2001–2024)
This chart tracks Yabao Pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 22 annual periods. For the full cash flow conversion analysis, see 600351 cash flow conversion.
Annual Capital Reinvestment Ratio for Yabao Pharmaceutical Group Co Ltd (2001–2024)
Year-by-year Capital Reinvestment Ratio for Yabao Pharmaceutical Group Co Ltd from 2001 to 2024. See 600351 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.07x | CN¥471.69 Million | CN¥34.66 Million | ▼ -63.4% |
| 2023 | 0.20x | CN¥497.55 Million | CN¥99.86 Million | ▲ +48.5% |
| 2022 | 0.14x | CN¥460.46 Million | CN¥62.23 Million | ▼ -37.8% |
| 2021 | 0.22x | CN¥437.50 Million | CN¥95.05 Million | ▲ +31.7% |
| 2020 | 0.17x | CN¥380.96 Million | CN¥62.87 Million | ▼ -55.3% |
| 2019 | 0.37x | CN¥425.17 Million | CN¥157.09 Million | ▲ +131.8% |
| 2018 | 0.16x | CN¥426.60 Million | CN¥68.01 Million | ▼ -74.0% |
| 2017 | 0.61x | CN¥161.73 Million | CN¥99.34 Million | ▲ +13.4% |
| 2016 | 0.54x | CN¥155.95 Million | CN¥84.46 Million | ▼ -23.6% |
| 2015 | 0.71x | CN¥143.47 Million | CN¥101.68 Million | ▼ -27.2% |
| 2014 | 0.97x | CN¥178.63 Million | CN¥173.84 Million | ▼ -44.2% |
| 2013 | 1.74x | CN¥56.80 Million | CN¥99.02 Million | ▼ -40.6% |
| 2011 | 2.94x | CN¥40.73 Million | CN¥119.56 Million | ▼ -70.9% |
| 2010 | 10.09x | CN¥18.57 Million | CN¥187.30 Million | ▲ +1278.1% |
| 2009 | 0.73x | CN¥368.56 Million | CN¥269.82 Million | ▼ -48.9% |
| 2008 | 1.43x | CN¥102.90 Million | CN¥147.56 Million | ▲ +384.1% |
| 2007 | 0.30x | CN¥105.69 Million | CN¥31.31 Million | ▼ -92.1% |
| 2006 | 3.77x | CN¥11.59 Million | CN¥43.70 Million | ▼ -8.7% |
| 2005 | 4.13x | CN¥26.40 Million | CN¥108.95 Million | ▲ +62.3% |
| 2004 | 2.54x | CN¥79.73 Million | CN¥202.81 Million | ▲ +125.7% |
| 2002 | 1.13x | CN¥24.29 Million | CN¥27.38 Million | ▲ +15.4% |
| 2001 | 0.98x | CN¥23.59 Million | CN¥23.04 Million | — |